Uwe Schlomann

1.4k total citations
28 papers, 945 citations indexed

About

Uwe Schlomann is a scholar working on Molecular Biology, Oncology and Immunology and Allergy. According to data from OpenAlex, Uwe Schlomann has authored 28 papers receiving a total of 945 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 11 papers in Oncology and 11 papers in Immunology and Allergy. Recurrent topics in Uwe Schlomann's work include Cell Adhesion Molecules Research (11 papers), Peptidase Inhibition and Analysis (9 papers) and HER2/EGFR in Cancer Research (7 papers). Uwe Schlomann is often cited by papers focused on Cell Adhesion Molecules Research (11 papers), Peptidase Inhibition and Analysis (9 papers) and HER2/EGFR in Cancer Research (7 papers). Uwe Schlomann collaborates with scholars based in Germany, United Kingdom and United States. Uwe Schlomann's co-authors include Jörg W. Bartsch, Harald Jockusch, Silvia Rathke‐Hartlieb, Christopher Nimsky, Shunsuke Yamamoto, Catharina Conrad, Barbara Carl, Julia Benzel, Andrew Docherty and Dirk Wildeboer and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Neuroscience and Analytical Biochemistry.

In The Last Decade

Uwe Schlomann

28 papers receiving 931 citations

Peers

Countries citing papers authored by Uwe Schlomann

Since Specialization

Citations

This map shows the geographic impact of Uwe Schlomann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Uwe Schlomann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Uwe Schlomann more than expected).

Fields of papers citing papers by Uwe Schlomann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Uwe Schlomann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Uwe Schlomann. The network helps show where Uwe Schlomann may publish in the future.

Co-authorship network of co-authors of Uwe Schlomann

This figure shows the co-authorship network connecting the top 25 collaborators of Uwe Schlomann. A scholar is included among the top collaborators of Uwe Schlomann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Uwe Schlomann. Uwe Schlomann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Nitro-fatty acids: promising agents for the development of new cancer therapeutics 2024 ·Trends in Pharmacological Sciences ·Jessica Roos, Georg Manolikakes, Uwe Schlomann, Anna Klinke, Francisco J. Schöpfer, Carola A. Neumann, Thorsten J. Maier	2
2	The Metalloprotease-Disintegrin ADAM8 Alters the Tumor Suppressor miR-181a-5p Expression Profile in Glioblastoma Thereby Contributing to Its Aggressiveness 2022 ·Frontiers in Oncology ·(unknown), (unknown), (unknown), Uwe Schlomann, Miriam H. A. Bopp, (unknown), (unknown), (unknown), (unknown), Mirza Pojskić, Christian Preußer, Elke Pogge von Strandmann, Barbara Carl, Christopher Nimsky, Jörg W. Bartsch	19
3	Right Heart Failure in Mice Upon Pressure Overload Is Promoted by Mitochondrial Oxidative Stress 2022 ·JACC Basic to Translational Science ·Marion Müller, (unknown), (unknown), (unknown), (unknown), (unknown), Torben Schubert, Dragan Opačić, Muhammed Gerçek, Vera Fortmeier, Daniel Dumitrescu, Uwe Schlomann, (unknown), Aleksandar Petrovic, (unknown), Hendrik Milting, Ralph T. Schermuly, Kai Friedrichs, Volker Rudolph, Anna Klinke	16
4	Degradome of soluble ADAM10 and ADAM17 metalloproteases 2019 ·Cellular and Molecular Life Sciences ·Franka Scharfenberg, Andreas O. Helbig, (unknown), Julia Benzel, Uwe Schlomann, Florian Peters, Rielana Wichert, (unknown), Dirk Schmidt‐Arras, Stefan Rose‐John, Catherine Moali, Stefan F. Lichtenthaler, Claus U. Pietrzik, Jörg W. Bartsch, Andreas Tholey, Christoph Becker‐Pauly	47
5	ADAM8 in invasive cancers: links to tumor progression, metastasis, and chemoresistance 2019 ·Clinical Science ·Catharina Conrad, Julia Benzel, (unknown), (unknown), Uwe Schlomann, Alexander Zarbock, Emily P. Slater, Christopher Nimsky, Jörg W. Bartsch	57
6	Simultaneous Detection of Metalloprotease Activities in Complex Biological Samples Using the PrAMA (Proteolytic Activity Matrix Assay) Method 2017 ·Methods in molecular biology ·Catharina Conrad, Miles A. Miller, Jörg W. Bartsch, Uwe Schlomann, Douglas A. Lauffenburger	6
7	ADAM8 expression in breast cancer derived brain metastases: Functional implications on MMP‐9 expression and transendothelial migration in breast cancer cells 2017 ·International Journal of Cancer ·Catharina Conrad, (unknown), Uwe Schlomann, Marion Roeßler, Axel Pagenstecher, Peter M. Anderson, Jane E. Preston, Jessica Pruessmeyer, Andreas Ludwig, (unknown), Roger D. Kamm, Rainer Ritz, Barbara Carl, Christopher Nimsky, Jörg W. Bartsch	45
8	Synthesis and biological evaluation of analogues of the potent ADAM8 inhibitor cyclo(RLsKDK) for the treatment of inflammatory diseases and cancer metastasis 2016 ·Bioorganic & Medicinal Chemistry ·(unknown), Anaïs F. M. Noisier, (unknown), Jörg W. Bartsch, Uwe Schlomann, Margaret A. Brimble	13
9	Expression of the zinc importer protein ZIP9/SLC39A9 in glioblastoma cells affects phosphorylation states of p53 and GSK-3β and causes increased cell migration 2016 ·BioMetals ·Nico Münnich, (unknown), Christer Högstrand, Uwe Schlomann, Christopher Nimsky, Jörg W. Bartsch	15
10	A colorimetric-based amplification system for proteinases including MMP2 and ADAM8 2015 ·Analytical Biochemistry ·Marcia L. Moss, Garrit Koller, Jörg W. Bartsch, (unknown), Uwe Schlomann, Fred Rasmussen	8
11	The metalloprotease-disintegrin ADAM8 contributes to temozolomide chemoresistance and enhanced invasiveness of human glioblastoma cells 2015 ·Neuro-Oncology ·(unknown), (unknown), Jörg W. Bartsch, Amalia M. Dolga, Uwe Schlomann, Catharina Conrad, (unknown), Oliver Schilling, Martin L. Biniossek, Carsten Culmsee, Herwig Strik, Garrit Koller, Barbara Carl, Christopher Nimsky	52
12	ADAM 8 expression in invasive breast cancer promotes tumor dissemination and metastasis 2013 ·EMBO Molecular Medicine ·Mathilde Romagnoli, Nora D. Mineva, Michael Polmear, Catharina Conrad, Srimathi Srinivasan, Delphine Loussouarn, Sophie Barillé‐Nion, Irene Georgakoudi, (unknown), Enda McDermott, Michael J. Duffy, Patricia M. McGowan, Uwe Schlomann, Maddy Parsons, Jörg W. Bartsch, Gail E. Sonenshein	80
13	ADAM9 Inhibition Increases Membrane Activity of ADAM10 and Controls α-Secretase Processing of Amyloid Precursor Protein 2011 ·Journal of Biological Chemistry ·Marcia L. Moss, Gary K. Powell, Miles A. Miller, Lori L. Edwards, Bin Qi, Qing‐Xiang Amy Sang, Bart De Strooper, Ina Tesseur, Stefan F. Lichtenthaler, Myriam Taverna, Julia Li Zhong, Colin Dingwall, (unknown), Uwe Schlomann, Pei Zhou, Linda G. Griffith, Douglas A. Lauffenburger, Robert M. Petrovich, Jörg W. Bartsch	52
14	Cleavage of Extracellular Matrix Molecules: a role for ADAM8 in tumour cell invasion 2010 ·The FASEB Journal ·(unknown), (unknown), Uwe Schlomann, Marc D. Zack, (unknown)	1
15	ADAM8/MS2/CD156, an Emerging Drug Target in the Treatment of Inflammatory and Invasive Pathologies 2009 ·Current Pharmaceutical Design ·Garrit Koller, Uwe Schlomann, (unknown), (unknown), Silvia Naus, Jörg W. Bartsch	35
16	Altered Heparan Sulfate Structure in Mice with Deleted NDST3 Gene Function 2008 ·Journal of Biological Chemistry ·Srinivas Reddy Pallerla, Roger Lawrence, Lars Lewejohann, Yi Pan, Tobias M. Fischer, Uwe Schlomann, (unknown), Jeffrey D. Esko, Kay Grobe	58
17	Progressive Loss of Striatal Neurons Causes Motor Dysfunction in MND2 Mutant Mice and Is Not Prevented by Bcl-2 2002 ·Experimental Neurology ·Silvia Rathke‐Hartlieb, Uwe Schlomann, Peter Heimann, Miriam H. Meisler, Harald Jockusch, Jörg W. Bartsch	27
18	The Metalloprotease Disintegrin ADAM8 2002 ·Journal of Biological Chemistry ·Uwe Schlomann, Dirk Wildeboer, Ailsa Webster, (unknown), Dagmar Zeuschner, Christopher G. Knight, Andrew Docherty, M. Lambert, (unknown), Harald Jockusch, Jörg W. Bartsch	137
19	Elevated expression of membrane type 1 metalloproteinase (MT1‐MMP) in reactive astrocytes following neurodegeneration in mouse central nervous system 2000 ·FEBS Letters ·Silvia Rathke‐Hartlieb, Petra Budde, Stefan Ewert, Uwe Schlomann, Martin S. Staege, Harald Jockusch, Jörg W. Bartsch, Jürgen Frey	31
20	Tumor Necrosis Factor α Induces a Metalloprotease-Disintegrin, ADAM8 (CD 156): Implications for Neuron–Glia Interactions during Neurodegeneration 2000 ·Journal of Neuroscience ·Uwe Schlomann, Silvia Rathke‐Hartlieb, Shunsuke Yamamoto, Harald Jockusch, Jörg W. Bartsch	110

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact